Affimed (AFMD) Stock Chart & Stock Price History → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free AFMD Stock Alerts $5.15 +0.08 (+1.58%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Affimed Stock Price Performance5 Day Performance-6.19%1 Month Performance-2.65%3 Month Performance-12.87%6 Month Performance+42.66%Year-To-Date Performance-17.60%1 Year Performance-36.73% Receive AFMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Affimed and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> AFMD Stock Chart for Saturday, April, 20, 2024 AFMD Chart by TradingView Affimed Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$5.07$5.15+1.58%$5.21$5.0063,707 shs$78.43 million04/18/2024$5.23$5.07-3.06%$5.29$5.0789,522 shs$77.22 million04/17/2024$5.34$5.23-2.06%$5.37$5.2032,756 shs$79.65 million04/16/2024$5.49$5.34-2.73%$5.50$5.1740,155 shs$81.33 million04/15/2024$5.75$5.49-4.52%$5.92$5.4258,462 shs$83.60 million04/12/2024$5.91$5.75-2.71%$6.00$5.6395,109 shs$87.57 million Get the Latest News and Ratings for AFMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Affimed and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$5.83$5.91+1.37%$5.97$5.62115,344 shs$89.99 million04/10/2024$6.10$5.83-4.43%$6.10$5.7271,648 shs$92.89 million04/09/2024$6.33$6.10-3.63%$6.39$6.0486,451 shs$92.90 million04/08/2024$6.48$6.33-2.31%$6.51$6.2073,320 shs$96.41 million04/05/2024$6.55$6.48-1.07%$6.52$6.20122,086 shs$98.69 million04/04/2024$6.66$6.55-1.65%$6.88$6.30143,344 shs$99.76 million04/03/2024$6.44$6.66+3.42%$7.24$6.40252,813 shs$101.43 million04/02/2024$6.35$6.44+1.42%$7.07$5.73323,255 shs$96.15 million04/01/2024$5.30$6.35+19.81%$6.43$5.21228,194 shs$94.81 million03/29/2024$5.30$5.30$5.43$5.1180,919 shs$79.13 million03/28/2024$5.33$5.30-0.56%$5.43$5.1180,904 shs$79.13 million03/27/2024$5.32$5.33+0.19%$5.65$5.3099,631 shs$79.58 million03/26/2024$5.19$5.32+2.50%$5.55$5.2057,635 shs$79.43 million03/25/2024$4.99$5.19+4.01%$5.19$4.8798,130 shs$77.49 million03/22/2024$5.04$4.99-0.99%$5.15$4.7768,734 shs$74.50 million03/21/2024$5.29$5.04-4.73%$5.49$5.0173,751 shs$75.25 million03/20/2024$5.10$5.29+3.73%$5.33$4.86105,022 shs$78.98 million03/19/2024$4.54$5.10+12.33%$5.14$4.55106,966 shs$76.14 million03/18/2024$4.57$4.54-0.66%$5.04$4.51100,286 shs$67.78 million03/15/2024$4.40$4.57+3.86%$4.70$4.3375,352 shs$68.23 million03/14/2024$4.79$4.40-8.14%$4.86$4.24243,193 shs$65.69 million03/13/2024$5.25$4.79-8.76%$5.37$4.79182,947 shs$71.52 million03/12/2024$5.38$5.25-2.42%$5.95$5.05196,261 shs$784.04 million03/11/2024$0.61$5.38+785.01%$6.74$5.28201,397 shs$803.45 million03/08/2024$5.82$0.61-89.56%$0.61$0.58604,457 shs$90.78 million03/07/2024$5.70$5.82+2.14%$6.29$5.6071,962 shs$86.95 million03/06/2024$6.69$5.70-14.80%$6.12$5.00289,261 shs$85.12 million03/05/2024$6.90$6.69-3.04%$7.20$6.2044,329 shs$99.91 million03/04/2024$6.70$6.90+2.99%$7.20$6.80147,192 shs$103.05 million03/01/2024$6.02$6.70+11.30%$6.96$6.00133,493 shs$100.06 million02/29/2024$5.90$6.02+2.03%$6.40$5.90122,551 shs$89.90 million02/28/2024$5.88$5.90+0.39%$6.04$5.7657,312 shs$88.11 million02/27/2024$5.60$5.88+5.02%$5.94$5.4180,671 shs$87.77 million02/26/2024$5.32$5.60+5.21%$5.70$5.2147,866 shs$79.43 millionBiden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story02/23/2024$5.33$5.32-0.21%$5.50$5.2447,139 shs$79.43 million02/22/2024$5.26$5.33+1.33%$5.60$5.2068,769 shs$79.60 million02/21/2024$5.51$5.26-4.52%$5.66$5.0056,320 shs$78.55 million02/20/2024$6.03$5.51-8.59%$6.10$5.3699,822 shs$82.27 million02/19/2024$6.03$6.03$6.03$5.7053,010 shs$90.01 million02/16/2024$5.80$6.03+3.99%$6.03$5.7050,545 shs$90.01 million02/15/2024$5.82$5.80-0.40%$6.00$5.6559,080 shs$86.56 million02/14/2024$5.77$5.82+0.85%$5.90$5.6527,395 shs$86.90 million02/13/2024$5.90$5.77-2.20%$6.05$5.5074,173 shs$86.17 million02/12/2024$5.48$5.90+7.76%$5.99$5.3595,432 shs$88.11 million02/09/2024$5.30$5.48+3.24%$5.60$5.2437,505 shs$81.76 million02/08/2024$5.50$5.30-3.63%$5.77$5.2137,823 shs$79.20 million02/07/2024$5.64$5.50-2.39%$5.89$5.4088,444 shs$82.18 million02/06/2024$5.23$5.64+7.80%$5.70$5.2031,383 shs$84.20 million02/05/2024$5.50$5.23-4.91%$5.40$5.1528,777 shs$78.11 million02/02/2024$5.58$5.50-1.43%$5.60$5.4123,757 shs$82.14 million02/01/2024$5.51$5.58+1.27%$5.65$5.3261,798 shs$83.33 million01/31/2024$5.34$5.51+3.18%$5.60$5.2125,943 shs$82.29 million01/30/2024$5.60$5.34-4.64%$5.67$5.1163,074 shs$79.75 million01/29/2024$5.68$5.60-1.41%$5.68$5.3535,885 shs$83.63 million01/26/2024$5.77$5.68-1.47%$5.80$5.4150,628 shs$84.83 million01/25/2024$5.71$5.77+0.96%$5.84$5.5034,738 shs$86.10 million01/24/2024$5.82$5.71-1.89%$5.87$5.5550,546 shs$85.27 million01/23/2024$5.80$5.82+0.34%$5.99$5.6027,617 shs$86.92 million01/22/2024$5.91$5.80-1.88%$6.00$5.7154,404 shs$86.62 million01/19/2024$6.03$5.91-2.02%$6.10$5.7263,636 shs$88.28 million Related Companies: CUE Stock Chart BYSI Stock Chart ETON Stock Chart IFRX Stock Chart CLSD Stock Chart MIST Stock Chart ONCY Stock Chart LPTX Stock Chart RZLT Stock Chart ASRT Stock Chart Receive AFMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Affimed and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AFMD) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affimed Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.